Effect of rivaroxaban on HIF-α, P-selectin and TNF-αin patients with lower extremity venous thrombosis
- VernacularTitle:利伐沙班对下肢静脉血栓患者HIF－α、P－选择素及TNF－α的影响研究
- Author:
Binbin SONG
;
Zhiguo WEN
- Publication Type:Journal Article
- Keywords:
rivaroxaban;
lower extremity venous thrombosis;
HIF-α;
P-selectin;
TNF-α
- From:
Chinese Journal of Biochemical Pharmaceutics
2015;37(7):82-84
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the effect of rivaroxaban on HIF-α, P-selectin and TNF-αin patients with lower extremity venous thrombosis.Methods 41 cases from May 2014 to February 2015 were selected and randomly divided into two groups, 21 cases in the control group were treated by routine treatment, 20 cases in the experiment group were treated on the base of the control group with ivaroxaban.Serum HIF-α, P-selectin and TNF-αwere detected before and after the treatment.ResuIts Compared with the control group, the clinical effect were higher ( P<0.05 ) , the adverse reactions occur rate was no difference (P>0.05).HIF-α, P-selectin and TNF-αwere lower(P<0.05),HIF-αwas positively correlated with TNF-α(r =-0.468,P<0.05), and was not correlated with P-selectin, P-selectin was not associated with TNF-α.ConcIusion Rivaroxaban can effectively improve the lower limb venous thrombosis in patients with clinical symptoms, reduce serum HIF-α, P-selectin and TNF-αexpression, has better clinical curative effect, for clinical treatment of lower limb venous thrombosis has important significance.
